Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 26:11:117.
doi: 10.3389/fncel.2017.00117. eCollection 2017.

The Serotonin Transporter and Early Life Stress: Translational Perspectives

Affiliations
Review

The Serotonin Transporter and Early Life Stress: Translational Perspectives

Danielle J Houwing et al. Front Cell Neurosci. .

Abstract

The interaction between the serotonin transporter (SERT) linked polymorphic region (5-HTTLPR) and adverse early life stressing (ELS) events is associated with enhanced stress susceptibility and risk to develop mental disorders like major depression, anxiety, and aggressiveness. In particular, human short allele carriers are at increased risk. This 5-HTTLPR polymorphism is absent in the rodent SERT gene, but heterozygous SERT knockout rodents (SERT+/-) show several similarities to the human S-allele carrier, therefore creating an animal model of the human situation. Many rodent studies investigated ELS interactions in SERT knockout rodents combined with ELS. However, underlying neuromolecular mechanisms of the (mal)adaptive responses to adversity displayed by SERT rodents remain to be elucidated. Here, we provide a comprehensive review including studies describing mechanisms underlying SERT variation × ELS interactions in rodents. Alterations at the level of translation and transcription but also epigenetic alterations considerably contribute to underlying mechanisms of SERT variation × ELS interactions. In particular, SERT+/- rodents exposed to adverse early rearing environment may be of high translational and predictive value to the more stress sensitive human short-allele carrier, considering the similarity in neurochemical alterations. Therefore, SERT+/- rodents are highly relevant in research that aims to unravel the complex psychopathology of mental disorders. So far, most studies fail to show solid evidence for increased vulnerability to develop affective-like behavior after ELS in SERT+/- rodents. Several reasons may underlie these failures, e.g., (1) stressors used might not be optimal or severe enough to induce maladaptations, (2) effects in females are not sufficiently studied, and (3) few studies include both behavioral manifestations and molecular correlates of ELS-induced effects in SERT+/- rodents. Of course, one should not exclude the (although unlikely) possibility of SERT+/- rodents not being sensitive to ELS. In conclusion, future studies addressing ELS-induced effects in the SERT+/- rodents should extensively study both long-term behavioral and (epi)genetic aspects in both sexes. Finally, further research is warranted using more severe stressors in animal models. From there on, we should be able to draw solid conclusions whether the SERT+/- exposed to ELS is a suitable translational animal model for studying 5-HTTLPR polymorphism and stress interactions.

Keywords: 5-HTTLPR; early life; gene × environment; human; rodent; serotonin transporter; stress.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different alterations in the human, rhesus, and rodent SERT gene resulting in changed transcription levels of SERT. (a) In humans and rhesus macaques having either a short or long allele for the 5-HTTLPR results in either lower or higher transcription levels respectively. Since rodents do not carry an orthologue of this polymorphism, knockout of the SERT can be achieved by (b) replacing exon 2 with a neo cassette (mice) or by (c) inducing a premature stop codon in exon 3 (rats) resulting in the absence of functional SERT protein.

Similar articles

Cited by

References

    1. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edn. Washington, DC: American Psychiatric Association.
    1. Anderson G. M., Gutknecht L., Cohen D. J., Brailly-Tabard S., Cohen J. H., Ferrari P., et al. . (2002). Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol. Psychiatry 7, 831–836. 10.1038/sj.mp.4001099 - DOI - PubMed
    1. Andrews K., Fitzgerald M. (1997). Barriers to optimal pain management in infants, children, and adolescents: biological barriers to paediatric pain management. Clin. J. Pain 13, 138–143. - PubMed
    1. Andrews P. W., Bharwani A., Lee K. R., Fox M., Thomson J. A. (2015). Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci. Biobehav. Rev. 51, 164–188. 10.1016/j.neubiorev.2015.01.018 - DOI - PubMed
    1. Angelucci F., Brenè S., Mathé A. A. (2005). BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10, 345–352. 10.1038/sj.mp.4001637 - DOI - PubMed